Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Corteva (CTVA) Research & Development (2018 - 2025)

Corteva has reported Research & Development over the past 8 years, most recently at $413.0 million for Q4 2025.

  • For Q4 2025, Research & Development rose 13.15% year-over-year to $413.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 5.14%, while the annual FY2025 figure was $1.5 billion, 5.14% up from the prior year.
  • Research & Development for Q4 2025 was $413.0 million at Corteva, up from $351.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $413.0 million in Q4 2025 and troughed at $268.0 million in Q1 2022.
  • A 5-year average of $330.8 million and a median of $333.5 million in 2023 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: decreased 4.63% in 2022 and later rose 17.91% in 2023.
  • Year by year, Research & Development stood at $316.0 million in 2021, then rose by 7.59% to $340.0 million in 2022, then grew by 5.0% to $357.0 million in 2023, then grew by 2.24% to $365.0 million in 2024, then rose by 13.15% to $413.0 million in 2025.
  • Business Quant data shows Research & Development for CTVA at $413.0 million in Q4 2025, $351.0 million in Q3 2025, and $375.0 million in Q2 2025.